Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT05399576
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 150 participants
- Sponsor
- The First Affiliated Hospital of Zhejiang Chinese Medical University
- Registry
-
NCT05399576
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05399576. Randomized; double masking; primary purpose prevention. Start 2022-05-17 (actual); primary completion 2023-05-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Nicorandil
- Intervention (Drug)
- Saline
- Lead sponsor
- The First Affiliated Hospital of Zhejiang Chinese Medical University
Record details
- Record id
cardio:ct-nct05399576- Content hash
ae00b12f73faabe955e3df9cd8a6572fbdffcd6a84f1f62a325c82e62b974900